[Elsevier] Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial |
|
This post will be closed automatically in 2026-08-29 17:55
Reward10points
|
| |
post
reply
points
2771
10
Environmental and economic life cycle assessment of thermal energy storage based on organic phase change material embedded in open-cell copper foams
10
Unleashing ZIF-8 mediated magnetic nanocatalyst for biodiesel synthesis: Optimization, thermo-kinetics, cost estimation, and green parametric analysis
10
Self-assembled ※3D-stereoscopic printing-like§ PANI-based porous carbon aerogels for high-efficiency CO2 adsorption
10
Optimality conditions for nonsmooth vector interval-valued bilevel optimization problems in terms of tangential subdifferentials
10
Archean eolian dynamics, deposits, and indicators of other weather phenomena: Lessons from Earth and Mars
